A molecular diagnostic test based on DNA methylation for early detection and diagnosis of gastric cancer. Supports risk stratification and early screening for gastric malignancies.
Manufactured by
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Acon Biotech (Hangzhou) Co., Ltd.
China · 3 relevant products
Clinomics Europe Kft.
Hungary · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 10 relevant products
GeneCker Co., Ltd.
South Korea · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
CheMOnitor Ltd.
Hungary · 2 relevant products
STRATEC/Diatron
Germany · 2 relevant products
Glycanostics, s.r.o.
Slovakia · 2 relevant products
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 91 closest product alternatives
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test providing precise tumor subtyping for improved treatment stratification. Supports personalized oncology management and therapeutic decision-making.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for inherited genetic disorder detection. Identifies mutations and genetic variations associated with hereditary diseases.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.
CheMOnitor Ltd. · Hungary
An in vitro diagnostic blood test designed to predict chemotherapy effectiveness in lung cancer patients at an early stage, before full treatment cycles are completed. The test analyzes N-glycan profiles using ultra-high resolution glycomics combined with AI-based data interpretation to provide oncologists with actionable treatment response predictions.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
Glycanostics, s.r.o. · Slovakia
Early-stage prostate cancer diagnostic test utilizing advanced glycan analysis for highly accurate detection. Designed to identify prostate cancer at initial stages, enabling timely clinical intervention and improved patient outcomes.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
79 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products